QYR Market Research Onychomycosis (Tinea Unguium) Drug Market Research | Page 3

QYResearch
• The Onychomycosis (Tinea Unguium) Drug industry was 2,675 million USD in
2017 and is projected to reach 2,905 million USD by 2022, at a CAGR
(Compounded Annual Growth Rate) of 1.66% between 2017 and 2022. The
market is driven by various end-user industries, such as Age under 18, Age
18-50 and Age above 50.
• The industry is concentration, the key brand include Johnson & Johnson, GSK,
Novartis, Pfizer, Valeant Pharma, Kaken Pharmaceutical, Galderma, Xiuzheng
Pharmaceutical, Letai, Qilu Pharmaceutical and so on. Among them, Johnson &
Johnson and GSK are the leaders.
Click to view the full report TOC, figure and tables：
https://www.qyresearch.com/index/detail/445154/global-
onychomycosis-tinea-unguium-drug-market
www.qyresearch.com